Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Chromatography|March 14, 1980
Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of manP A Reece, I Cozamanis, R ZacestEuropean Journal of Clinical Pharmacology|January 1, 1982
Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazineP A Reece, I Cozamanis, R ZacestEuropean Journal of Clinical Pharmacology|January 1, 1983
Endralazine - a new hydralazine-like antihypertensive with high systemic bioavailabilityP A Reece, I Cozamanis, R ZacestJournal of Chromatography|September 11, 1981
Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasmaP A Reece, I Cozamanis, R ZacestJournal of Pharmaceutical Sciences|August 1, 1978
Interference in assays for hydralazine in humans by a major plasma metabolite, hydralazine pyruvic acid hydrazoneP A Reece, P E Stanley, R ZacestJournal of Pharmaceutical Sciences|February 1, 1985
Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteersP A Reece, I Stafford, R H Prager, et al.The Medical Journal of Australia|January 4, 1975
The clinical pharmacology of hypotensive vasodilator drugsR ZacestAustralian and New Zealand Journal of Medicine|August 1, 1976
The vasodilator--beta-blocker interaction--some determinants of its clinical successR ZacestEuropean Journal of Clinical Pharmacology|January 3, 1977
The ambiguity of adverse drug reactionsJ Koch-Weser, E M Sellers, R ZacestJournal of Chromatography|February 8, 1980
Simple and selective high-performance liquid chromatographic method for estimating plasma quinidine levelsP A Reece, M PeikertPageof 4